Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM
/PRNewswire/ -- Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, is pleased to announce that it has received...
Stay updated with breaking news from Alpha Da. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, is pleased to announce that it has received...
Founded in 2016, Alpha Tau developed a breakthrough cancer treatment called Alpha DaRT (Dіffusіng Alpha-emіtters Radіatіon Therapy).
Alpha Tau Medical Announces Appointment of Peter Melnyk as New Board Member USA - English Share this article Share this article JERUSALEM, Jan. 12, 2021 /PRNewswire/ -- Alpha Tau Medical, the developer of breakthrough Alpha DaRT (Diffusing alpha-emitters Radiation Therapy), is pleased to announce the appointment of Peter Melnyk to its Board of Directors. Mr. Melnyk is the CEO of Fortovia Therapeutics, a commercial stage, private equity-owned pharmaceutical company focused on oncology supportive care products. Prior to that, he held leading roles in sales, marketing, and business development i...